45 Stocks Moving In Monday's Mid-Day Session
45 Stocks Moving In Monday's Mid-Day Session
Gainers
贏家
Aterian, Inc. (NASDAQ:ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets.
Itamar Medical Ltd. (NASDAQ:ITMR) shares climbed 44.8% to $30.16. ZOLL Medical Corporation, an Asahi Kasei company, agreed to acquire Itamar Medical for a total value of approximately $538 million.
iRhythm Technologies, Inc. (NASDAQ:IRTC) shares surged 33.1% to $64.06. iRhythm Technologies named Quentin Blackford as President and Chief Executive Officer.
aTyr Pharma, Inc. (NASDAQ:LIFE) rose 24% to $6.81 as the company announced positive results from its Phase 1b/2a trial evaluating its lead therapeutic candidate, ATYR1923, in pulmonary sarcoidosis, a major form of interstitial lung disease.
Datasea Inc. (NASDAQ:DTSS) gained 22.8% to $2.5558 after the company reported a $4.33 million contract to 'provide short message and 5G multimedia message services.'
Uranium Royalty Corp. (NASDAQ:UROY) jumped 22.3% to $4.28 after climbing over 10% on Friday.
REGENXBIO Inc. (NASDAQ:RGNX) gained 22.2% to $40.43 after the company, and AbbVie, announced an eye care collaboration. AbbVie to pay REGENXBIO $370 million in upfront payment and up to $1.38 billion in milestones.
Mersana Therapeutics, Inc. (NASDAQ:MRSN) rose 22.2% to $10.46 after tumbling 39% on Friday.
Leap Therapeutics, Inc. (NASDAQ:LPTX) jumped 19% to $1.7359 after declining around 3% on Friday. Leap Therapeutics, last month, reported a Q2 loss of $0.12 per share.
Central Puerto S.A. (NYSE:CEPU) rose 18.9% to $3.2090 after declining around 3% on Friday.
Mayville Engineering Company, Inc. (NYSE:MEC) gained 18.3% to $16.48.
Ocugen, Inc. (NASDAQ:OCGN) surged 17% to $8.36. WHO’s nod to Bharat Biotech's COVID-19 Vaccine, Covaxin is expected this week, according to reports. Ocugen is a partner with Bharat Biotech on COVID-19 vaccine.
Aehr Test Systems (NASDAQ:AEHR) rose 14.7% to $11.60. Aehr recently received $19.4 million order for multiple FOX-XP test and burn-in systems from a major automotive semiconductor supplier.
CareMax, Inc. (NASDAQ:CMAX) gained 14.6% to $10.78. Piper Sandler upgraded CareMax from Neutral to Overweight.
Ring Energy, Inc. (NYSE:REI) surged 13.3% to $2.72. The company, last month, reported upbeat Q2 results.
Grupo Financiero Galicia S.A. (NASDAQ:GGAL) shares rose 13.1% to $11.94.
Immunome, Inc. (NASDAQ:IMNM) gained 12.7% to $21.02. Immunome's three-antibody cocktail (IMM-BCP-01) recently demonstrated potent neutralizing activity against SARS-CoV-2 Lambda (C.37) and Delta AY.1/2 (Delta Plus) variants in preclinical testing.
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) jumped 12.6% to $26.30. Raymond James upgraded NGM Biopharmaceuticals from Outperform to Strong Buy and raised the price target from $27 to $39.
SmileDirectClub, Inc. (NASDAQ:SDC) gained 12.6% to $5.81.
Banco Macro S.A. (NYSE:BMA) shares climbed 12.3% to $20.53. The company, last month, released Q2 results.
Pampa Energía S.A. (NYSE:PAM) rose 11.7% to $18.59. The company released Q2 results last month.
Aluminum Corporation of China Limited (NYSE:ACH) climbed 8.6% to $23.30 after dropping over 4% on Friday.
Document Security Systems, Inc. (NYSE:DSS) rose 6% to $1.4312. Alset Ehome International recently completed a subscription agreement with Document Security Systems.
Aterian，Inc.(納斯達克：晚些時候)跳漲54.1%，報18.18美元。週五發佈的投資者演示文稿現在正在新聞媒體上流傳。
伊塔瑪醫療有限公司(納斯達克：ITMR)股價攀升44.8%，至30.16美元。旭化成旗下的Zoll醫療株式會社同意以總價值約5.38億美元的價格收購伊塔瑪醫療。
IRhythm技術公司(納斯達克：IRTC)股價飆升33.1%，至64.06美元。IRhythm Technologies任命昆汀·布萊克福德為總裁兼首席執行官。
ATyr製藥公司(納斯達克：生活)上漲24%，至6.81美元，該公司宣佈了其1b/2a期試驗的積極結果，該試驗評估了其治療肺結節病的主要候選藥物ATYR1923。肺結節病是一種主要的間質性肺部疾病。
Datasea。(納斯達克：DTSS)股價上漲22.8%，至2.5558美元，此前該公司公佈了一份價值4，33萬美元的合同，將提供短信和5G彩信服務。
鈾礦開採公司。(納斯達克：UROY)跳漲22.3%，報4.28美元，上週五曾攀升逾10%。
Regenxbio Inc.(納斯達克：RGNX)上漲22.2%，至40.43美元，此前該公司和AbbVie宣佈達成眼部護理合作。AbbVie將向Regenxbio支付3.7億美元的預付款和高達13.8億美元的里程碑費用。
Mersana治療公司(納斯達克：MRSN)上漲22.2%，至10.46美元，上週五暴跌39%。
Leap治療公司(納斯達克：LPTX)躍升19%，至1.7359美元，上週五下跌約3%。Leap治療公司上個月報告第二季度每股虧損0.12美元。
南卡羅來納州波多黎各中部(紐約證券交易所：CEPU)上漲18.9%，至3.2090美元，上週五下跌約3%。
梅維爾工程公司(紐約證券交易所：MEC)上漲18.3%，至16.48美元。
Ocugen，Inc.(納斯達克：OCGN)急升17%，報8.36美元。據報道，巴拉特生物技術公司的新冠肺炎疫苗有望在本週上市。歐庫根是巴拉特生物技術公司在新冠肺炎疫苗方面的合作伙伴。
Aehr測試系統(納斯達克：AEHR)上漲14.7%，至11.60美元。Aehr最近從一家主要的汽車半導體供應商那裏收到了價值1940萬美元的多個Fox-XP測試和老化系統的訂單。
CareMax，Inc.(納斯達克：CMAX)上漲14.6%，至10.78美元。派珀·桑德勒將CareMax評級從中性上調至增持。
RING能源公司(紐約證券交易所：雷伊)急升13.3%，報2.72美元。上個月，該公司公佈了樂觀的第二季度業績。
Grupo Financiero Galicia S.A.(納斯達克：GGAL)股價上漲13.1%，至11.94美元。
免疫組織公司(納斯達克：IMNM)上漲12.7%，至21.02美元。免疫組的三抗雞尾酒(IMM-BCP-01)最近在臨牀前試驗中顯示出對SARS-CoV-2 Lambda(c.37)和Delta AY.1/2(Delta Plus)變異株的強大中和活性。
NGM生物製藥公司(納斯達克：NGM)跳漲12.6%，報26.30美元。Raymond James將NGM BiopPharmticals評級從表現優於大盤上調至Strong Buy，並將目標價從27美元上調至39美元。
SmileDirectClub，Inc.(納斯達克：SDC)上漲12.6%，至5.81美元。
Banco宏觀銀行(紐約證券交易所：BMA)股價攀升12.3%，至20.53美元。上個月，該公司發佈了第二季度業績。
潘帕能源公司(紐約證券交易所：帕姆)上漲11.7%，至18.59美元。該公司上個月發佈了第二季度業績。
中國鋁業有限公司(紐約證券交易所：阿奇)攀升8.6%，至23.30美元，上週五下跌逾4%。
文檔安全系統公司(紐約證券交易所：決策支持系統)上漲6%，至1.4312美元。Alset Ehome International最近完成了與Document Security Systems的訂閲協議。
Losers
失敗者
MiMedx Group, Inc. (NASDAQ:MDXG) shares dipped 59.7% to $6.26 after announcing top-line results from two musculoskeletal trials of micronized dehydrated Human Amnion Chorion Membrane (mdHACM). Top-line results from an interim analysis of the six-month efficacy data for the Phase 2B trial for Knee Osteoarthritis (KOA) did not meet primary endpoints.
Farmmi, Inc. (NASDAQ:FAMI) shares fell 50.5% to $0.2849 after the company announced a 368,261,717 share public offering to be priced at $0.22 per share.
Valneva SE (NASDAQ:VALN) fell 39.6% to $28.26 after the company announced it received a termination notice from the UK Government in relation to the Supply Agreement for its COVID-19 vaccine candidate, VLA2001.
Silverback Therapeutics, Inc. (NASDAQ:SBTX) fell 26.5% to $14.29. Silvermack Therapeutics will present data from Phase 1/1b clinical trial of SBT6050 at the European Society for Medical Oncology (ESMO) 2021 Congress.
AXT, Inc. (NASDAQ:AXTI) dipped 23.8% to $7.03.
VIQ Solutions Inc. (NASDAQ:VQS) shares fell 16.5% to $4.00 after the company reported a $18 million registered direct offering.
Lyell Immunopharma, Inc. (NASDAQ:LYEL) dropped 16.3% to $15.03.
Dynavax Technologies Corporation (NASDAQ:DVAX) shares fell 16.2% to $14.70 after the company announced Valneva received a termination notice from the United Kingdom government in relation to Valneva's supply agreement for its COVID-19 vaccine candidate, VLA2001.
China XD Plastics Company Limited (NASDAQ:CXDC) fell 15.3% to $0.4651 after the company received Nasdaq delisting letter. The company also said it intends to request a hearing before a Nasdaq Hearings Panel.
Riskified Ltd. (NYSE:RSKD) fell 14.5% to $24.69. The company, last week, reported Q2 EPS results down from last year.
Mammoth Energy Services, Inc. (NASDAQ:TUSK) tumbled 14.4% to $2.85.
Cadiz Inc. (NASDAQ:CDZI) dropped 14% to $8.85. The company issued a statement on recent stock volatility.
Rocket Lab USA, Inc. (NASDAQ:RKLB) dropped 13.3% to $16.21. Cowen & Co. initiated coverage on Rocket Lab USA with a Market Perform rating and announced a price target of $18.
SEMrush Holdings, Inc. (NYSE:SEMR) fell 13.1% to $27.23.
Dada Nexus Limited (NASDAQ:DADA) declined 13% to $22.43.
CS Disco, Inc. (NYSE:LAW) dropped 12.6% to $57.39 as the company reported a proposed secondary public offering of common stock.
Porch Group, Inc. (NASDAQ:PRCH) dipped 12.2% to $19.52.
So-Young International Inc. (NASDAQ:SY) fell 10.3% to $4.78. The company, last week, reported Q2 earnings results.
Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) fell 10.2% to $10.42 after dipping over 25% on Friday. Virpax Pharmaceuticals filed for offering of 3.4 million shares of common stock.
U.S. Well Services, Inc. (NASDAQ:USWS) shares fell 8% to $0.6980 after dropping around 4% on Friday. U.S. Well Services, last month, posted a quarterly loss of $0.15 per share.
Advaxis, Inc. (NASDAQ:ADXS) fell 7.1% to $0.5576. Advaxis shares climbed over 28% on Friday after the company reported better-than-expected Q3 earnings results and provided a business update.
RLX Technology Inc. (NYSE:RLX) fell 6.4% to $5.38 after dropping around 17% on Friday.
MiMedx集團公司(納斯達克：MDXG)股價下跌59.7%，至6.26美元，此前該公司宣佈了兩項微粉化脱水人羊膜絨毛膜(MdHACM)肌肉骨骼試驗的主要結果。對膝骨性關節炎(KOA)2B期試驗6個月療效數據的中期分析得出的主要結果不符合主要終點。
農米良品公司(納斯達克：族)股價下跌50.5%，至0.2849美元，此前該公司宣佈以每股0.22美元的價格公開發行368,261,717股票。
Valneva SE(納斯達克：山谷)下跌39.6%，至28.26美元，此前該公司宣佈收到英國政府關於其新冠肺炎候選疫苗VLA2001供應協議的終止通知。
銀背治療公司(納斯達克：SBTX)下跌26.5%，至14.29美元。Silvermack Treateutics將在歐洲醫學腫瘤學會(ESMO)2021年大會上公佈SBT6050的1/1b期臨牀試驗數據。
Axt，Inc.(納斯達克：AXTI)下跌23.8%，至7.03美元。
VIQ解決方案公司(納斯達克：VQS)股價下跌16.5%，至4.00美元，此前該公司公佈將進行1,800萬美元的註冊直接發行。
萊爾免疫公司。(納斯達克：萊爾)下跌16.3%，至15.03美元。
戴納瓦克斯技術公司(納斯達克：DVAX)股價下跌16.2%，至14.70美元，此前該公司宣佈，Valneva收到了英國政府關於Valneva為其新冠肺炎候選疫苗VLA2001的供應協議的終止通知。
鑫達集團有限公司(納斯達克：CXDC)大跌15.3%，報0.4651美元，此前該公司收到納斯達克退市通知書。該公司還表示，打算要求納斯達克聽證會小組舉行聽證會。
瑞斯基尼有限公司(紐約證券交易所：RSKD)下跌14.5%，至24.69美元。該公司上週公佈的第二季度每股收益較去年有所下降。
猛獁象能源服務公司(納斯達克：圖斯克)暴跌14.4%，報2.85美元。
Cadiz Inc.(納斯達克：CDZI)下跌14%，至8.85美元。該公司就最近的股票波動發表了一份聲明。
火箭實驗室美國公司(納斯達克：RKLB)下跌13.3%，至16.21美元。Cowen&Co.以市場表現評級啟動了對火箭實驗室美國的報道，並宣佈目標價為18美元。
SEMRUSH控股公司(紐約證券交易所：SEMR)下跌13.1%，至27.23美元。
達達集團(納斯達克：達達)下跌13%，至22.43美元。
CS Disco，Inc.(紐約證券交易所：法律)股價下跌12.6%，至57.39美元，該公司公佈擬進行普通股二次公開發行。
博奇集團有限公司(納斯達克：PRCH)下跌12.2%，至19.52美元。
新氧。(納斯達克：賽)下跌10.3%，至4.78美元。該公司上週公佈了第二季度收益業績。
Virpax製藥公司(納斯達克：VRPX)下跌10.2%，至10.42美元，上週五下跌逾25%。Virpax製藥公司申請發行340萬股普通股。
美國油井服務公司(納斯達克：USWS)股價下跌8%，至0.6980美元，上週五下跌約4%。美國韋爾服務公司上個月公佈季度每股虧損0.15美元。
Advax，Inc.(納斯達克：ADXS)下跌7.1%，至0.5576美元。Advaxis股價週五攀升逾28%，此前該公司公佈了好於預期的第三季度收益業績，並提供了業務最新情況。
霧芯科技公司(紐約證券交易所：RLX)下跌6.4%，至5.38美元，上週五下跌約17%。
譯文內容由第三人軟體翻譯。